The Venture Codex Logo

The Venture Codex

Mount Venture Capital Fund

25-28 Old Burlington Street, London, England, W1S 3AN, United Kingdom

Overview

Mount Venture Capital Fund is a private investment firm that focuses on early-stage health, sports, and medical startups. The fund invests in companies that develop innovative products and technologies aimed at improving people’s health, well-being, and athletic performance.

Total investments
3
Lead investments
1
Investments · 12mo
2
Active investors
1

Sector focus

  • Health Care
Visit website

Investment portfolio

  • Incard

    Participated · Series A · Feb 2026

    Incard is a London-based financial platform built to replace the patchwork of traditional business banking tools used by fast-growing digital companies. Launched in 2024 by entrepreneurs Theo Cesarini, Soraya Tribouillois, Liam Seskis, and Matteo Martino, the product combines business banking, corporate cards, and connected bank accounts in a single interface. Users can extend functionality through the Incard App Store, adding modules for invoicing, spend management, treasury, working capital, and other industry-specific workflows. The platform provides real-time cash-flow visibility, spend insights, and automation features to help companies manage multi-entity structures, high advertising spend, and foreign-exchange exposure. Adoption has come primarily from high-growth digital firms across the UK and Europe. Looking ahead, Incard intends to enter additional European markets and the United States, while enhancing AI-driven financial workflows and expanding its engineering, compliance, and product teams. The company plans to deepen automation capabilities and widen its app ecosystem to support customers at various stages of growth.

  • Synthax

    Participated · Equity · Oct 2025

    Synthax is developing a cloud-based, AI-driven operating system designed specifically for outpatient clinics. Its platform automates tasks from patient intake and clinical documentation through to billing, combining workflow automation, AI decision support, and real-time data insights. By reducing administrative burden, the company aims to let clinicians focus more on patient care and help smaller clinics compete with larger health systems. The system is targeted at both U.S. and U.K. outpatient providers, with the team planning to scale commercial adoption across these markets. Fresh capital will be used to expand Synthax’s engineering team and accelerate product development. Headquartered in London and founded by Dr. Shaheer Aslam Joiya and Mark Murtagh, Synthax positions itself within the healthtech SaaS sector. No revenue, user, or other operating metrics were disclosed in the article.

  • CaseCraft.AI

    Led · Equity · Jun 2025

    CaseCraft.AI has developed a proprietary platform to assist individuals and businesses across the UK in filing and defending small claims, with a focus on helping users reach settlements before court action. The platform targets the Small Claims Track, which handles civil disputes valued at £10,000 or less (or £1,000 or less for personal injury or housing disrepair). Typical use cases include unpaid invoices, faulty goods, and tenancy deposit disputes. CaseCraft.AI plans to deploy the funds to further develop, test, and refine its Small Claims platform while scaling marketing to reach a broader audience. The company also intends to expand its team, recruiting product and engineering talent to harness advances in AI for consumer-facing solutions. Financially, CaseCraft.AI secured £550,000 in funding at a £3,000,000 pre-money valuation, with Moun Fund leading the round.

Team